- call +1-201-465-4211
- email sales@mrinsights.biz
Alopecia drugs are being used for unapproved clinical indication or extension to a milder form of approved indication or extension to related conditions. For instance, alopecia market heavily uses spironolactone and cyclosporine, which are primarily approved for other indications.
Scope of the Report:
This report focuses on the Alopecia Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global topical drugs market segment accounted for the maximum market share during 2017 and will continue to dominate the market until the end of 2025. Topical drugs are widely used in comparison to oral formulations. The increasing availability and popularity of new drugs, such as the AVODART drug, will fuel the growth prospects for the market during the forecast period.
The worldwide market for Alopecia Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
GlaxoSmithKline
Johnson & Johnson
Merck
Aclaris Therapeutics
Polichem
Promius Pharma
Ranbaxy Laboratories
Reckitt Benckiser
Regience
Samumed
RepliCel
Skinvisible Pharmaceuticals
Teva Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral Alopecia Drugs
Topical Alopecia Drugs
Injectable Alopecia Drugs
Market Segment by Applications, can be divided into
Hospitals
Specialty Clinics
There are 15 Chapters to deeply display the global Alopecia Drugs market.
Chapter 1, to describe Alopecia Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Alopecia Drugs, with sales, revenue, and price of Alopecia Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Alopecia Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Alopecia Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Alopecia Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Alopecia Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Oral Alopecia Drugs
1.2.2 Topical Alopecia Drugs
1.2.3 Injectable Alopecia Drugs
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Specialty Clinics
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 Alopecia Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline Alopecia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Alopecia Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Alopecia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Alopecia Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Alopecia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Aclaris Therapeutics
2.4.1 Business Overview
2.4.2 Alopecia Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Aclaris Therapeutics Alopecia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Polichem
2.5.1 Business Overview
2.5.2 Alopecia Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Polichem Alopecia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Promius Pharma
2.6.1 Business Overview
2.6.2 Alopecia Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Promius Pharma Alopecia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Ranbaxy Laboratories
2.7.1 Business Overview
2.7.2 Alopecia Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ranbaxy Laboratories Alopecia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Reckitt Benckiser
2.8.1 Business Overview
2.8.2 Alopecia Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Reckitt Benckiser Alopecia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Regience
2.9.1 Business Overview
2.9.2 Alopecia Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Regience Alopecia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Samumed
2.10.1 Business Overview
2.10.2 Alopecia Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Samumed Alopecia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 RepliCel
2.11.1 Business Overview
2.11.2 Alopecia Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 RepliCel Alopecia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Skinvisible Pharmaceuticals
2.12.1 Business Overview
2.12.2 Alopecia Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Skinvisible Pharmaceuticals Alopecia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Teva Pharmaceutical
2.13.1 Business Overview
2.13.2 Alopecia Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Teva Pharmaceutical Alopecia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Alopecia Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Alopecia Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Alopecia Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Alopecia Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Alopecia Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Alopecia Drugs Market Analysis by Regions
4.1 Global Alopecia Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Alopecia Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Alopecia Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Alopecia Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Alopecia Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Alopecia Drugs Sales and Growth Rate (2013-2018)
4.5 South America Alopecia Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Alopecia Drugs Sales and Growth Rate (2013-2018)
5 North America Alopecia Drugs by Countries
5.1 North America Alopecia Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Alopecia Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Alopecia Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Alopecia Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Alopecia Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Alopecia Drugs Sales and Growth Rate (2013-2018)
6 Europe Alopecia Drugs by Countries
6.1 Europe Alopecia Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Alopecia Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Alopecia Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Alopecia Drugs Sales and Growth Rate (2013-2018)
6.3 UK Alopecia Drugs Sales and Growth Rate (2013-2018)
6.4 France Alopecia Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Alopecia Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Alopecia Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Alopecia Drugs by Countries
7.1 Asia-Pacific Alopecia Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Alopecia Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Alopecia Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Alopecia Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Alopecia Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Alopecia Drugs Sales and Growth Rate (2013-2018)
7.5 India Alopecia Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Alopecia Drugs Sales and Growth Rate (2013-2018)
8 South America Alopecia Drugs by Countries
8.1 South America Alopecia Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Alopecia Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Alopecia Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Alopecia Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Alopecia Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Alopecia Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Alopecia Drugs by Countries
9.1 Middle East and Africa Alopecia Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Alopecia Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Alopecia Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Alopecia Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Alopecia Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Alopecia Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Alopecia Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Alopecia Drugs Sales and Growth Rate (2013-2018)
10 Global Alopecia Drugs Market Segment by Type
10.1 Global Alopecia Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Alopecia Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Alopecia Drugs Revenue and Market Share by Type (2013-2018)
10.2 Oral Alopecia Drugs Sales Growth and Price
10.2.1 Global Oral Alopecia Drugs Sales Growth (2013-2018)
10.2.2 Global Oral Alopecia Drugs Price (2013-2018)
10.3 Topical Alopecia Drugs Sales Growth and Price
10.3.1 Global Topical Alopecia Drugs Sales Growth (2013-2018)
10.3.2 Global Topical Alopecia Drugs Price (2013-2018)
10.4 Injectable Alopecia Drugs Sales Growth and Price
10.4.1 Global Injectable Alopecia Drugs Sales Growth (2013-2018)
10.4.2 Global Injectable Alopecia Drugs Price (2013-2018)
11 Global Alopecia Drugs Market Segment by Application
11.1 Global Alopecia Drugs Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Specialty Clinics Sales Growth (2013-2018)
12 Alopecia Drugs Market Forecast (2018-2023)
12.1 Global Alopecia Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Alopecia Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Alopecia Drugs Market Forecast (2018-2023)
12.2.2 Europe Alopecia Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Alopecia Drugs Market Forecast (2018-2023)
12.2.4 South America Alopecia Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Alopecia Drugs Market Forecast (2018-2023)
12.3 Alopecia Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Alopecia Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Alopecia Drugs Market Share Forecast by Type (2018-2023)
12.4 Alopecia Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Alopecia Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Alopecia Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Alopecia Drugs Picture
Table Product Specifications of Alopecia Drugs
Figure Global Sales Market Share of Alopecia Drugs by Types in 2017
Table Alopecia
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
